KEL Gene (Kell Blood Group System) Hemolytic Anemia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين KEL (نظام فصيلة الدم كيل) لفقر الدم الانحلالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary (الموجز التنفيذي)

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited NGS processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection" and VIP Mobile Phlebotomy (8 AM – 11 PM, all emirates).
Clinical Guidance: Complimentary telephonic post-test clinical guidance in result interpretation with a DHA-licensed genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

This advanced Next-Generation Sequencing (NGS) genetic test analyses the KEL gene to identify variants associated with Kell blood group system-related haemolytic anaemia. It is performed on blood, extracted DNA, or a single drop of blood on an FTA card, delivering actionable insights within 3 to 4 weeks for personalised clinical management.

يقوم هذا التحليل الجيني المتقدم بفحص جين KEL لتحديد الطفرات المرتبطة بفقر الدم الانحلالي الناتج عن نظام فصيلة الدم كيل، ويستخدم تقنية التسلسل الجيني من الجيل التالي (NGS) على عينات الدم أو الحمض النووي المستخلص.

Feature	Our Test	Closest Alternative
Precision	>99.9% analytical sensitivity & specificity (NGS)	Standard serological phenotyping (indirect)
Methodology	Full KEL gene sequencing via NGS (Illumina® platform)	Allele-specific PCR or limited exon sequencing
Turnaround	3–4 weeks with genetic counselling	4–6 weeks, often without integral counselling

Physician Insight & Safety Protocol

“Dr. PRABHAKAR REDDY (DHA License: 61713011): Every KEL genetic result must be interpreted within the context of your complete clinical picture and family history. This test identifies genetic predisposition, not an active haemolytic state; therefore, it should always be accompanied by a consultation with your haematologist or clinical geneticist.”

⚠ Medication & Safety Warning

Do not discontinue any prescribed medication or alter treatment plans without explicit guidance from your treating physician. Genetic information alone does not replace ongoing clinical monitoring.

Exclusion Criteria & Emergency Red Flags:

Ages below 18 years require court-authorised consent per UAE CDS Law 2026.
Active haemolytic crisis or acute anaemia – proceed to the emergency department before testing.
Suspected Kell-related neonatal isoimmunisation requires immediate obstetric referral, not elective genetic testing.

Patient FAQ & Clinical Guidance

1. What exactly does the KEL gene NGS test detect?

This test comprehensively sequences the entire KEL gene to identify pathogenic variants, polymorphisms, and alleles linked to Kell blood group system-related haemolytic anaemia. It can detect both well-characterised mutations and novel variants that standard serological typing cannot identify, offering the highest genetic resolution for diagnosis, carrier screening, and family planning decisions.

يكشف هذا التحليل جميع الطفرات المرتبطة بجين KEL المسببة لفقر الدم الانحلالي الناتج عن نظام فصيلة الدم كيل، ويتفوق على الطرق المصلية التقليدية في تحديد الحاملين والطفرات النادرة.

2. Can I use a home collection service for this test across the UAE?

Absolutely, we offer DHA-licensed VIP home phlebotomy from 8 AM to 11 PM in all seven emirates, using ISO-certified cold-chain transport to preserve DNA integrity. The phlebotomist arrives with a refrigerated kit, collects blood or an FTA card, and guarantees chain-of-custody – no clinic visit is required unless you prefer one.

نعم، نوفر خدمة سحب الدم المنزلي المعتمدة من هيئة الصحة بدبي في جميع أنحاء الإمارات، مع نقل مبرد للحفاظ على العينة، ولا حاجة لزيارة المختبر.

3. How should I prepare for the genetic counselling session before the?

Before sample collection, you must attend a genetic counselling session (virtual or in-person) to document a detailed pedigree chart of family members affected by Kell-related haemolytic anaemia. Please gather all relevant medical records, previous blood transfusion history, and known case records of haemolytic disease in newborns – this information is critical for accurate variant interpretation and risk assessment.

يجب حضور جلسة استشارة وراثية قبل سحب العينة، لإعداد شجرة العائلة وتوثيق تاريخ الحالات المرضية لفقر الدم الانحلالي، مع إحضار التقارير الطبية السابقة.

UAE Compliance: Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), UAE PDPL. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. Support: +971545488731.

دعم ثنائي اللغة متاح